Spatial heterogeneity of extensively drug resistant-tuberculosis in Western Cape Province, South Africa

Tuberculosis (TB) remains a leading infectious disease killer globally. Treatment outcomes are especially poor among people with extensively drug-resistant (XDR) TB, until recently defined as rifampicin-resistant (RR) TB with resistance to an aminoglycoside (amikacin) and a fluoroquinolone (ofloxaci...

Descripción completa

Detalles Bibliográficos
Autores principales: Sy, Karla Therese L., Leavitt, Sarah V., de Vos, Margaretha, Dolby, Tania, Bor, Jacob, Horsburgh, C. Robert, Warren, Robin M., Streicher, Elizabeth M., Jenkins, Helen E., Jacobson, Karen R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237070/
https://www.ncbi.nlm.nih.gov/pubmed/35760977
http://dx.doi.org/10.1038/s41598-022-14581-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237070/
https://www.ncbi.nlm.nih.gov/pubmed/35760977
http://dx.doi.org/10.1038/s41598-022-14581-4

Ejemplares similares